[Skip to Content]
[Skip to Content Landing]
Views 233
Citations 0
Comment & Response
November 5, 2019

Spontaneous Breathing Trials and Successful Extubation—Reply

Author Affiliations
  • 1Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Spain
JAMA. 2019;322(17):1717. doi:10.1001/jama.2019.14244

In Reply We agree with Drs Friedrich and Burns that prophylaxis against postextubation respiratory failure with NIV or HFNC was more common in the PSV group than in the T-piece group (24.7% vs 18.7%).1 However, the decision to apply prophylaxis was made before randomization, so this difference can only be attributed to chance. We would like to clarify that patients could receive prophylactic NIV or HFNC but not both.